Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 1
1945 14
1946 50
1947 71
1948 64
1949 53
1950 90
1951 111
1952 69
1953 122
1954 86
1955 112
1956 87
1957 89
1958 115
1959 108
1960 78
1961 101
1962 182
1963 395
1964 671
1965 449
1966 503
1967 645
1968 885
1969 946
1970 1156
1971 1391
1972 1123
1973 1073
1974 1023
1975 770
1976 638
1977 589
1978 523
1979 475
1980 524
1981 607
1982 625
1983 682
1984 724
1985 806
1986 846
1987 800
1988 886
1989 900
1990 905
1991 973
1992 974
1993 831
1994 830
1995 798
1996 709
1997 647
1998 692
1999 636
2000 733
2001 727
2002 689
2003 598
2004 766
2005 852
2006 887
2007 919
2008 938
2009 921
2010 903
2011 967
2012 923
2013 886
2014 829
2015 821
2016 741
2017 689
2018 571
2019 329
2020 24
Text availability
Article attribute
Article type
Publication date

Search Results

44,126 results
Results by year
Filters applied: . Clear all
Page 1
VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
Keating D, Marigowda G, Burr L, Daines C, Mall MA, McKone EF, Ramsey BW, Rowe SM, Sass LA, Tullis E, McKee CM, Moskowitz SM, Robertson S, Savage J, Simard C, Van Goor F, Waltz D, Xuan F, Young T, Taylor-Cousar JL; VX16-445-001 Study Group. Keating D, et al. N Engl J Med. 2018 Oct 25;379(17):1612-1620. doi: 10.1056/NEJMoa1807120. Epub 2018 Oct 18. N Engl J Med. 2018. PMID: 30334692 Free PMC article. Clinical Trial.
VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
Davies JC, Moskowitz SM, Brown C, Horsley A, Mall MA, McKone EF, Plant BJ, Prais D, Ramsey BW, Taylor-Cousar JL, Tullis E, Uluer A, McKee CM, Robertson S, Shilling RA, Simard C, Van Goor F, Waltz D, Xuan F, Young T, Rowe SM; VX16-659-101 Study Group. Davies JC, et al. N Engl J Med. 2018 Oct 25;379(17):1599-1611. doi: 10.1056/NEJMoa1807119. Epub 2018 Oct 18. N Engl J Med. 2018. PMID: 30334693 Free PMC article. Clinical Trial.
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.
Middleton PG, Mall MA, Dřevínek P, Lands LC, McKone EF, Polineni D, Ramsey BW, Taylor-Cousar JL, Tullis E, Vermeulen F, Marigowda G, McKee CM, Moskowitz SM, Nair N, Savage J, Simard C, Tian S, Waltz D, Xuan F, Rowe SM, Jain R; VX17-445-102 Study Group. Middleton PG, et al. N Engl J Med. 2019 Nov 7;381(19):1809-1819. doi: 10.1056/NEJMoa1908639. Epub 2019 Oct 31. N Engl J Med. 2019. PMID: 31697873 Clinical Trial.
Thermal constraints on in vivo optogenetic manipulations.
Owen SF, Liu MH, Kreitzer AC. Owen SF, et al. Nat Neurosci. 2019 Jul;22(7):1061-1065. doi: 10.1038/s41593-019-0422-3. Epub 2019 Jun 17. Nat Neurosci. 2019. PMID: 31209378 Free PMC article.
Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming.
Green JP, Yu S, Martín-Sánchez F, Pelegrin P, Lopez-Castejon G, Lawrence CB, Brough D. Green JP, et al. Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9371-E9380. doi: 10.1073/pnas.1812744115. Epub 2018 Sep 19. Proc Natl Acad Sci U S A. 2018. PMID: 30232264 Free PMC article.
Iron(iii) chloride-catalyzed activation of glycosyl chlorides.
Geringer SA, Demchenko AV. Geringer SA, et al. Org Biomol Chem. 2018 Dec 5;16(47):9133-9137. doi: 10.1039/c8ob02413h. Org Biomol Chem. 2018. PMID: 30430182 Free PMC article.
44,126 results
Jump to page
Feedback